Lanean...
PARP Inhibitors: The First Synthetic Lethal Targeted Therapy
PARP inhibitors (PARPi), a cancer therapy targeting poly(ADP-ribose) polymerase, are the first clinically approved drugs designed to exploit synthetic lethality, a genetic concept proposed nearly a century ago. Tumors arising in patients who carry germline mutations in either BRCA1 or BRCA2 are sens...
Gorde:
| Argitaratua izan da: | Science |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6175050/ https://ncbi.nlm.nih.gov/pubmed/28302823 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/science.aam7344 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|